NCT07167485

Brief Summary

Sleep deprivation is common in intensive care. Impaired sleep quality and quantity and altered circadian rhythms have been observed. Polysomnography is the gold standard for sleep analysis. However, it is difficult to perform due to technical constraints and the lack of a consensus definition of the different stages of sleep for intensive care patients. Alternative methods to polysomnography would be useful for better defining sleep disturbances. There are many factors that can disrupt sleep, including environmental disturbances, sedative drugs, mechanical ventilation, and the severity of the condition that led to the patient's admission to intensive care. The consequences of this deprivation include immune system disorders, neuropsychiatric disorders, and impaired functional recovery. Therapeutic management is currently limited, as no drug treatments have been shown to improve sleep quality. Furthermore, no ventilation method has been proven effective in improving sleep. Finally, regulating environmental disturbances-aiming to reduce light exposure, limit noise, and respect day/night rhythms-could improve sleep in intensive care patients. According to recent data, individual measures such as protective eye masks and earplugs have not improved patients' sleep architecture. The aim of our study is therefore to highlight the benefits of the withdrawal and rehabilitation unit (USR) in improving the quality of sleep in intensive care patients. The quality of sleep in intensive care patients in our department will be assessed using a questionnaire validated for intensive care patients, the Richard-Campbell questionnaire (RCSQ). We will also analyse various known risk factors for sleep disturbance in intensive care and USR patients.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
42

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started Dec 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 16, 2022

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 6, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 6, 2025

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

September 4, 2025

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 11, 2025

Completed
Last Updated

September 11, 2025

Status Verified

May 1, 2025

Enrollment Period

2.5 years

First QC Date

September 4, 2025

Last Update Submit

September 4, 2025

Conditions

Keywords

Detoxification and rehabilitation unit

Outcome Measures

Primary Outcomes (1)

  • Assessing the quality of sleep in intensive care patients over time

    Sleep quality according to the Richard-Campbell questionnaire (RCSQ) score. The Richards Campbell Sleep Questionnaire is a widely used sleep quality instrument comprising visual analogue scales (VAS) 0-100 mm allowing assessment of sleep depth, falling asleep, number of awakenings, percent of time awake, and overall quality of sleep domains. The higher the score, the better the quality of sleep.

    At enrollment visit and Day 14

Secondary Outcomes (1)

  • Compare sleep recovery rates according to hospital unit (intensive care or withdrawal and rehabilitation unit, USR).

    At enrollment visit and Day 14

Interventions

Sleep quality will be assessed each night in intensive care using a Richards-Campbell sleep questionnaire and an intensive care sleep questionnaire, completed by the patient.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

intensive care patients

You may qualify if:

  • over 18 years of age
  • clinically stable (no amines or sedation for more than 48 hours)
  • hospitalised for more than 7 days in intensive care
  • conscious
  • with no central neurological pathology
  • with no major cognitive impairment
  • with no sleep disorder (OSA, insomnia, restless legs syndrome)

You may not qualify if:

  • Age \< 18 years old Patient refusal Person deprived of liberty by administrative or judicial decision or protected adult (under guardianship or trusteeship); Patient unable, for whatever reason, to read, understand or answer questionnaires (visual impairment, psychiatric or cognitive disorders, etc.).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Rouen Hospital

Rouen, 76031, France

Location

Study Design

Study Type
observational
Observational Model
CASE ONLY
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 4, 2025

First Posted

September 11, 2025

Study Start

December 16, 2022

Primary Completion

June 6, 2025

Study Completion

June 6, 2025

Last Updated

September 11, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

The data provided will be the property of the sponsor and will be used solely for its own research activities.

Locations